CORC

在结果中检索

CORC

浏览/检索结果: 共121条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
PD-L1 Aptamer-Functionalized Metal-Organic Framework Nanoparticles for Robust Photo-Immunotherapy against Cancer with Enhanced Safety 期刊论文
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 9
作者:  Zhang, Jingfang;  Li, Wenzhe;  Qi, Yafei;  Wang, Guorong;  Li, Lele
收藏  |  浏览/下载：14/0  |  提交时间：2023/02/22
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文
BMC Medicine, 2022, 卷号: 20, 期号: 1
作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun
收藏  |  浏览/下载：123/0  |  提交时间：2022/11/21
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
收藏  |  浏览/下载：21/0  |  提交时间：2022/12/22
Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo 期刊论文
NANO TODAY, 2022, 卷号: 44
作者:  Wang, Wenbin;  Sun, Hui;  Gong, Yan;  Liu, Xiangsheng;  Liu, Xiao
收藏  |  浏览/下载：116/0  |  提交时间：2022/12/23
A study of AK104 (an anti-PD1 and anti-CTLA4 bispecific antibody) combined with standard therapy for the first-line treatment of persistent, recurrent, or metastatic cervical cancer (R/M CC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Wang, Jing;  Lou, Hanmei;  Cai, Hong-Bing;  Huang, Xin;  Li, Guiling
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23
A phase Ib/II study of AK112, a PD-1/VEGF bispecific antibody, as first- or second-line therapy for advanced non-small cell lung cancer (NSCLC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Zhou, Caicun;  Ren, Shengxiang;  Luo, Yongzhong;  Wang, Lei;  Xiong, Anwen
收藏  |  浏览/下载：16/0  |  提交时间：2022/12/23
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 页码: 23
作者:  He, Bing-Xi;  Zhong, Yi-Fan;  Zhu, Yong-Bei;  Deng, Jia-Jun;  Fang, Meng-Jie
收藏  |  浏览/下载：31/0  |  提交时间：2022/06/10
Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer 期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:  Li, Yue;  Li, Chong;  Jiang, Ya;  Han, Xue;  Liu, Sisi
收藏  |  浏览/下载：15/0  |  提交时间：2022/12/23
Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2022
作者:  Xu, Liwei;  Qi, Yajun;  Jiang, Youhua;  Ji, Yongling;  Zhao, Qiang
收藏  |  浏览/下载：30/0  |  提交时间：2022/05/05
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：29/0  |  提交时间：2022/05/05

©版权所有 ©2017 CSpace - Powered by CSpace